Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans.

Breast Cancer Res Treat 2008 Jul 2;110(2):367-76. Epub 2007 Oct 2.

Department of Health Studies, University of Chicago, Chicago, IL, USA.

The UDP-glucuronosylatransferase 1A1 (UGT1A1) gene is involved in the metabolism of estrogen and detoxification of potential carcinogens. The number of TA repeats in the promoter region of UGT1A1 has been linked to breast cancer risk, but results varied by race. We performed a comprehensive assessment of genetic polymorphisms in the UGT1A1 gene, and examined these polymorphisms and TA repeats in relation to breast cancer risk in a case-control study in Nigeria. 512 breast cancer cases and 226 community controls were genotyped for UGT1A1. Compared with high-activity TA repeat genotypes, the odds ratios (OR) for low-activity and moderate-activity genotypes were 0.47 (95% confidence interval CI, 0.26-0.83) and 0.64 (95% CI, 0.39-1.06), respectively, in premenopausal women (P = 0.009 for trend), but no association was observed in postmenopausal women (P = 0.24). The effect of TA repeats was also differentiated by age: the OR was 0.39 (95% CI 0.21-0.71) for low-activity genotypes and 0.58 (95% CI 0.33-1.00) for moderate-activity genotypes in women <45 years old (P = 0.002 for trend), but no association was observed in women >or=45 years old (P = 0.15). Haplotype analysis showed that UGT1A1 haplotypes were highly diverse with blocked structures. We found a specific haplotype in block 2 that was significantly associated with a 2.1-fold elevated risk (95% CI 1.05-4.39; P = 0.04). In contrast with previous studies, we found low-activity TA repeat alleles were protective against breast cancer among premenopausal indigenous Africans, suggesting that the role of UGT1A1 in breast cancer development may vary by population, presumably due to different environmental and genetic modifier effects.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9720-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384416PMC
July 2008
24 Reads

Publication Analysis

Top Keywords

breast cancer
24
cancer risk
12
moderate-activity genotypes
8
genetic polymorphisms
8
ugt1a1 gene
8
ugt1a1
6
breast
6
cancer
6
95%
5
age 039
4
024 repeats
4
differentiated age
4
observed postmenopausal
4
039 95%
4
women 024
4
postmenopausal women
4
repeats differentiated
4
low-activity genotypes
4
95% 033-100
4
033-100 moderate-activity
4

References

(Supplied by CrossRef)

RH Tukey et al.
Annu Rev Pharmacol Toxicol 2000

PI Mackenzie et al.
Pharmacogenet Genomics 2005

SB Senafi et al.
Biochem J 1994

C Guillemette et al.
Cancer Res 2000

PJ Bosma et al.
N Engl J Med 1995

C Guillemette et al.
Cancer Epidemiol Biomarkers Prev 2001

EG Shatalova et al.
Mol Biol (Mosk) 2006

OJ Adegoke et al.
Breast Cancer Res Treat 2004

TC Cheng et al.
Int J Cancer 2005

C Balram et al.
Pharmacogenetics 2002

F Innocenti et al.
Pharmacogenetics 2002

Similar Publications